Close Menu

Infectious Disease

News on research and diagnostic development for pathogenic diseases.

After nearly a year in development, the firm's rapid antigen test will be submitted by the end of March for a prescription-use claim.

The test is designed to help determine if a patient has an acute respiratory infection and if that infection is bacterial or viral.

The test uses a technology called Switch-Blocker that is co-owned by the companies and enables both viral detection and strain discrimination.

The investment bank said that Lucira's COVID-19 single-use test could have widespread use with potential for adoption in the over-the-counter markets.

The RT-PCR-based test is designed to detect three SARS-CoV-2 genes in saliva samples collected in the presence of a trained observer.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Apr
06
Sponsored by
Beckman Coulter

In this webinar session, Dr. David Harris and Dr. Ryan Sprissler, who led the student and employee testing program at University of Arizona, will discuss how the university has remained physically open with nearly 25 percent of its population on campus, while keeping infection rates below 2 percent.